The DOI matches its Crossref record; 46 of the 48 references it cites were found in a registry or an index.
Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma
Abstract
Retinoblastoma clinical observations revealed the role of tumor suppressor genes in human cancer, Knudson's 'two-hit' model of cancer induction. We now demonstrate that loss of both RB1 tumor suppressor gene alleles initiates quiescent RB1(-/-) retinomas with low level genomic instability and high expression of the senescence-associated proteins p16(INK4a) and p130. Although retinomas can remain unchanged throughout life, highly proliferative, clonal and aneuploid retinoblastomas commonly emerge, exhibiting altered gene copy number and expression of oncogenes (MYCN, E2F3, DEK, KIF14 and MDM4) and tumor suppressor genes (CDH11, p75(NTR)) and reduced expression of p16(INK4a) and p130. We suggest that RB1 inactivation in developing retina induces genomic instability, but senescence can block transformation at the stage of retinoma. However, stable retinoma is rarely clinically observed because progressive genomic instability commonly leads to highly proliferative retinoblastoma.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“it is well-accepted that loss of RB is the initiating event in these familial retinal tumours, as well as in sporadic cases15–17.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [17]
In the citing paper
“It has been suggested that this type of chromosomal instability is linked to the progression of benign eye lesions to malignant retinoblastoma17.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [17]
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
Oncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220
Inactivation of the p53 pathway in retinoblastoma
Laurie, N. A., Donovan, S. L., Shih, C.-S., Zhang, J., Mills, N., Fuller, C., Teunisse, A., Lam, S., Ramos, Y., Mohan, A., et al. (2006) · Nature · doi:10.1038/nature05194 · Cited by 595
Hernando, E., Nahlé, Z., Juan, G., Diaz-Rodriguez, E., Alaminos, M., Hemann, M., Michel, L., Mittal, V., Gerald, W., Benezra, R., et al. (2004) · Nature · doi:10.1038/nature02820 · Cited by 562
The natural history of incidentally detected small renal masses
Volpe, A., Panzarella, T., Rendon, R. A., Haider, M. A., Kondylis, F. I., & Jewett, M. A. S. (2004) · Cancer · doi:10.1002/cncr.20025 · Cited by 526
Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene
Stolle, C. A., Glenn, G. M., Zbar, B., Humphrey, J. S., Choyke, P. L., Walther, M. M., Pack, S., Hurley, K., Andrey, C., Klausner, R. D., et al. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)12:6<431::aid-humu10>3.0.co;2-y · Cited by 477
Chemotherapy With Focal Therapy Can Cure Intraocular Retinoblastoma Without Radiotherapy
Gallie, B. L. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140521001 · Cited by 416
Self-citation
Research works printed but not linked: 2
- Radnot, 1977, [Elements of photoreceptors in retinoblastomas (author's transl)], Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 202, 63
- Yilmaz, 1998, Twelve novel RB1 gene mutations in patients with hereditary retinoblastoma. Mutations in brief no. 206. Online, Hum. Mutat., 12, 434, 10.1002/(SICI)1098-1004(1998)12:6<434::AID-HUMU16>3.0.CO;2-7 · DOI
Cited by
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974
Cell cycle kinases as therapeutic targets for cancer
Lapenna, S., & Giordano, A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2907 · Cited by 905
Dimaras, H., Kimani, K., Dimba, E. A., Gronsdahl, P., White, A., Chan, H. S., & Gallie, B. L. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61137-9 · Cited by 669
Self-citationDimaras, H., Corson, T. W., Cobrinik, D., White, A., Zhao, J., Munier, F. L., Abramson, D. H., Shields, C. L., Chantada, G. L., Njuguna, F., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.21 · Cited by 553
Self-citationRushlow, D. E., Mol, B. M., Kennett, J. Y., Yee, S., Pajovic, S., Thériault, B. L., Prigoda-Lee, N. L., Spencer, C., Dimaras, H., Corson, T. W., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70045-7 · Cited by 420
Self-citationHerschkowitz, J. I., He, X., Fan, C., & Perou, C. M. (2008) · Breast Cancer Research · doi:10.1186/bcr2142 · Cited by 255
“As opposed to breast cancer, there is a great deal known about the mechanisms of RB1 loss in retinoblastoma [ 60-62 ].”
BackgroundXu, X. L., Fang, Y., Lee, T. C., Forrest, D., Gregory-Evans, C., Almeida, D., Liu, A., Jhanwar, S. C., Abramson, D. H., & Cobrinik, D. (2009) · Cell · doi:10.1016/j.cell.2009.03.051 · Cited by 246
“and premalignant retinomas have greatly increased CDKN2A expression (Laurie et al., 2006; Chen et al., 2007; Dimaras et al., 2008), it appears that the ARF-induced apoptotic response may be impaired in early stages of retinoblastoma tumorigenesis.”
Loss of pRB causes centromere dysfunction and chromosomal instability
Manning, A. L., Longworth, M. S., & Dyson, N. J. (2010) · Genes & Development · doi:10.1101/gad.1917310 · Cited by 240
Rb suppresses human cone-precursor-derived retinoblastoma tumours
Xu, X. L., Singh, H. P., Wang, L., Qi, D.-L., Poulos, B. K., Abramson, D. H., Jhanwar, S. C., & Cobrinik, D. (2014) · Nature · doi:10.1038/nature13813 · Cited by 235
Munier, F. L., Beck-Popovic, M., Chantada, G. L., Cobrinik, D., Kivelä, T. T., Lohmann, D., Maeder, P., Moll, A. C., Carcaboso, A. M., Moulin, A., et al. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.05.005 · Cited by 215
“With regard to this hypothesis, non-proliferative RB1−/− retinoma lesions were found to be present at the base of some, and perhaps most, retinoblastoma tumors (Dimaras et al., 2008), suggesting that small retinoma-like lesions might be present but imperceptible at birth and later reactivate to form retinoblastoma tum…”
InfluentialDi Fiore, R., D'Anneo, A., Tesoriere, G., & Vento, R. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24329 · Cited by 201
“…been thereafter described as required for the physical interaction of RB proteins with a variety of cellular proteins believed to work with RB proteins in transcriptional regulation, including human D-type cyclins (Dowdy et al., 1993), BRG1 (Dunaief et al., 1994), and HDAC1 (Brehm et al., 1998).”
BackgroundThe genomic landscape of retinoblastoma: a review
Thériault, B. L., Dimaras, H., Gallie, B. L., & Corson, T. W. (2014) · Clinical & Experimental Ophthalmology · doi:10.1111/ceo.12132 · Cited by 196
“These findings point to KIF14 gain as a possible M3 event.(13,18) Gene-specific analysis of retinomas via fluorescence in-situ hybridization confirmed that KIF14 gain was present in all retinomas studied, whereas gain of MDM4 was present in a smaller proportion of cases.”
BackgroundResultInfluentialSelf-citationRetinoblastoma, the visible CNS tumor: A review
Dimaras, H., & Corson, T. W. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24213 · Cited by 178
“eyes enucleated for retinoblastoma (Dimaras et al. 2008; Eagle 2009).”
InfluentialSelf-citationEagle Jr, R. C. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.8.1203 · Cited by 176
Self-citationPearson, J. D., Huang, K., Pacal, M., McCurdy, S. R., Lu, S., Aubry, A., Yu, T., Wadosky, K. M., Zhang, L., Wang, T., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.06.016 · Cited by 175
“Strikingly, YAP/TAZ were absent in human retinoblastoma, but expressed in retinoma (Figure 1C), an RB1–/–, but benign, postmitotic ‘‘dead-end’’ or barrier for progression (Dimaras et al., 2008).”
BackgroundSelf-citationFabian, I. D., Abdallah, E., Abdullahi, S. U., Abdulqader, R. A., Abdulrahaman, A. A., Abouelnaga, S., Ademola-Popoola, D. S., Adio, A., Afifi, M. A., Afshar, A. R., et al. (2022) · The Lancet Global Health · doi:10.1016/s2214-109x(22)00250-9 · Cited by 165
Self-citationGenetics and Molecular Diagnostics in Retinoblastoma — An Update
(2017) · Asia-Pacific Journal of Ophthalmology · doi:10.22608/apo.201711 · Cited by 161
Self-citationRB: mitotic implications of a tumour suppressor
Manning, A. L., & Dyson, N. J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3216 · Cited by 176
Genetics and Epigenetics of Human Retinoblastoma
Benavente, C. A., & Dyer, M. A. (2015) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040259 · Cited by 147
“www.annualreviews.org Human Retinoblastoma 549 cytokinesis.”
BackgroundMethodInfluentialHuman Embryonic Stem Cell-Derived Organoid Retinoblastoma Reveals a Cancerous Origin
Liu, H., Zhang, Y., Zhang, Y.-Y., Li, Y.-P., Hua, Z.-Q., Zhang, C.-J., Jin, S., Zhang, C.-J., Wu, K.-C., Su, J., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011780117 · Cited by 142
“H ), while few cells in normal organoids continued to divide. p16 INK4a ( CDKN2A ), which has been used as a potential marker to distinguish retinoma cells (Rb precursors, Ki67 − ) from Rb and retina (29), stained strongly positive in hRBOs (Fig.”
Galindo, C. R., Orbach, D. B., & VanderVeen, D. K. (2014) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2014.09.014 · Cited by 183
Berry, J. L., Xu, L., Kooi, I. E., Murphree, A. L., Prabakar, R. K., Reid, M., Stachelek, K., Le, B. H. A., Welter, L. M., Reiser, B. J., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0369 · Cited by 132
“Additional genetic changes can further drive tumorigenesis (14, 15).”
BackgroundLoss of Rb proteins causes genomic instability in the absence of mitogenic signaling
van Harn, T., Foijer, F., van Vugt, M. A. T. M., Banerjee, R., Yang, F., Oostra, A. B., Joenje, H., & Riele, H. T. (2010) · Genes & Development · doi:10.1101/gad.580710 · Cited by 132
“Loss of function of the RB1 gene is the initiator event in retinoblastoma, a pediatric cancer of the eye (Corson and Gallie 2007; Dimaras et al. 2008).”
BackgroundInfluentialOrtiz, M. V., & Dunkel, I. J. (2015) · Journal of Child Neurology · doi:10.1177/0883073815587943 · Cited by 126
“’’ This benign lesion develops after both RB1 alleles have been knocked out but before additional genomic instability has led to development of retinoblastoma.(48,49) The premalignant retinoma/retinocytoma has the potential to develop into retinoblastoma but often does not require any intervention other than close mon…”
Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes
Kooi, I. E., Mol, B. M., Massink, M. P. G., Ameziane, N., Meijers-Heijboer, H. E. J., Dommering, C. J., van Mil, S. E., de Vries, Y., van der Hout, A. H., Kaspers, G. J. L., et al. (2016) · Scientific Reports · doi:10.1038/srep25264 · Cited by 125
Retinoblastoma: Etiology, Modeling, and Treatment
Kaewkhaw, R., & Rojanaporn, D. (2020) · Cancers · doi:10.3390/cancers12082304 · Cited by 121
“However, some other premalignant cells (weak orange) undergo cell cycle arrest and senesce, becoming retinoma that often develop into retinoblastoma [3,17].”
BackgroundInfluentialLiu, J., Ottaviani, D., Sefta, M., Desbrousses, C., Chapeaublanc, E., Aschero, R., Sirab, N., Lubieniecki, F. J., Lamas, G., Tonon, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25792-0 · Cited by 122
Mendoza, P. R., & Grossniklaus, H. E. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.06.012 · Cited by 114
Yang, Z., Li, C., Yan, C., Li, J., Yan, M., Liu, B., Zhu, Z., Wu, Y., & Gu, Q. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.039 · Cited by 103
Emerging roles of RB family: New defense mechanisms against tumor progression
Indovina, P., Marcelli, E., Casini, N., Rizzo, V., & Giordano, A. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24170 · Cited by 100
“Furthermore, CIN, resulting from RB1/p105 loss, seems to be involved in the progression from retinoma, a benign eye lesion, to RB (Dimaras et al., 2008). van Harn et al. (2010) showed that triple knockout (TKO) mouse embryonic fibroblasts (MEFs) lacking the three members of Rb gene family, under…”
BackgroundOverexpression of the Cellular DEK Protein Promotes Epithelial Transformation In vitro and In vivo
Wise-Draper, T. M., Mintz-Cole, R. A., Morris, T. A., Simpson, D. S., Wikenheiser‐Brokamp, K. A., Currier, M. A., Cripe, T. P., Grosveld, G. C., & Wells, S. I. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2304 · Cited by 92
Gene expression profiling identifies different sub-types of retinoblastoma
Kapatai, G., Bründler, M.-A., Jenkinson, H. C., Kearns, P. R., Parulekar, M., Peet, A. C., & McConville, C. M. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.283 · Cited by 96
“It has been reported, for example, that loss of RB1 in humans induced non-proliferative retinoma and that increasing genome instability was correlated with progression to retinoblastoma (Dimaras et al, 2008).”
BackgroundDirect Involvement of Retinoblastoma Family Proteins in DNA Repair by Non-homologous End-Joining
Cook, R., Zoumpoulidou, G., Luczynski, M. T., Rieger, S., Moquet, J., Spanswick, V. J., Hartley, J. A., Rothkamm, K., Huang, P. H., & Mittnacht, S. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.059 · Cited by 97
“by Non-homologous End-Joining”
BackgroundPriest, J. R., Williams, G. M., Manera, R., Jenkinson, H. C., Bründler, M., Davis, S., Murray, T. G., GALLIANI, C. A., & Dehner, L. P. (2010) · British Journal of Ophthalmology · doi:10.1136/bjo.2010.189779 · Cited by 88
“36 Molecular investigations clarifying the evolution of retinoma into Rb have not yet been extended to the biology of PPB-related cysts.(33) Table 1 Clinical presentation, ophthalmologic features and management of CBME cases associated with PPB”
BackgroundHe, X., Chai, P., Li, F., Zhang, L., Zhou, C., Yuan, X., Li, Y., Yang, J., Luo, Y., Ge, S., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01232-3 · Cited by 97
Thériault, B. L., Pajovic, S., Bernardini, M. Q., Shaw, P. A., & Gallie, B. L. (2011) · International Journal of Cancer · doi:10.1002/ijc.26189 · Cited by 89
“The most prevalent karyotypic abnormality in retinoblastoma following RB1 loss is gain of the long arm of chromosome 1.(4,5) Subsequently, 1q gain was shown to be common in breast, lung, liver, papillary renal cell and OvCas.”
BackgroundSelf-citationMcEvoy, J., Ulyanov, A., Brennan, R., Wu, G., Pounds, S., Zhang, J., & Dyer, M. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042739 · Cited by 80
pRB, a tumor suppressor with a stabilizing presence
Manning, A. L., & Dyson, N. J. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.05.003 · Cited by 94
“Recent studies suggest that homozygous mutation of RB1 leads to the appearance of benign retinomas that subsequently progress to retinoblastoma [40].”
BackgroundSingh, H. P., Wang, S., Stachelek, K., Lee, S., Reid, M. W., Thornton, M. E., Craft, C. M., Grubbs, B. H., & Cobrinik, D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808903115 · Cited by 78
“Loss of functional RB protein in the cell of origin is thought to enable limited proliferation leading to premalignant retinomas, from which rare cells escape to form retinoblastoma tumors (2).”
BackgroundInfluentialLoss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression
Kooi, I. E., Mol, B. M., Moll, A. C., van der Valk, P., de Jong, M. C., de Graaf, P., van Mil, S. E., Meeteren, A. Y. N. S., Meijers-Heijboer, H. E. J., Kaspers, G. J. L., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.06.022 · Cited by 83
Afshar, A. R., Pekmezci, M., Bloomer, M. M., Cadenas, N., Stevers, M., Banerjee, A., Roy, R., Olshen, A. B., Ziffle, J. V., Onodera, C. S., et al. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2019.12.005 · Cited by 76
Kooi, I. E., Mol, B. M., Massink, M. P. G., de Jong, M. C., de Graaf, P., van der Valk, P., Meijers-Heijboer, H. E. J., Kaspers, G. J. L., Moll, A. C., Riele, H. T., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153323 · Cited by 76
“However, while bi-allelic inactivation of RB1 can cause benign retinoma lesions, additional genetic alterations can be required for progression to retinoblastoma [5].”
BackgroundInfluentialRetinoblastoma. Fifty Years of Progress. The LXXI Edward Jackson Memorial Lecture
Grossniklaus, H. E. (2014) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2014.07.025 · Cited by 84
“Dimaras and associates found that loss of both copies of RB1 may lead to retinoma (retinocytoma) and progressive genomic instability in retinoma then leads to retinoblastoma.(71) Gallie’s laboratory found that additional mutational events (‘‘3 hits’’) were required for progression to a fully a malignant tumor.”
BackgroundTomar, S., Sethi, R., Sundar, G., Quah, T. C., Quah, B. L., & Lai, P. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178776 · Cited by 82
Retinoblastoma for Pediatric Ophthalmologists
AlAli, A., Kletke, S. N., Gallie, B. L., & Lam, W.-C. (2017) · Asia-Pacific Journal of Ophthalmology · doi:10.22608/apo.201870 · Cited by 74
Self-citationRenal Tumor Natural History: the Rationale and Role for Active Surveillance
Jewett, M. A. S., & Zúñiga, Á. (2008) · Urologic Clinics of North America · doi:10.1016/j.ucl.2008.07.004 · Cited by 71
The pathology of ocular cancer
Eagle, R. C. (2012) · Eye · doi:10.1038/eye.2012.237 · Cited by 71
Self-citationLohmann, D. R. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6448-9_21 · Cited by 73
Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma
Sachdeva, U. M., & O’Brien, J. M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci57114 · Cited by 67
MDM2 as a Modifier Gene in Retinoblastoma
Castéra, L., Sabbagh, A., Dehainault, C., Michaux, D., Mansuet‐Lupo, A., Patillon, B., Lamar, E., Aerts, I., Rouïc, L. L.-L., Couturier, J., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq416 · Cited by 67
Management and outcome of unilateral retinoblastoma
Mallipatna, A. C., Sutherland, J. E., Gallie, B. L., Chan, H. S. L., & Héon, E. (2009) · Journal of American Association for Pediatric Ophthalmology and Strabismus · doi:10.1016/j.jaapos.2009.09.004 · Cited by 67
Self-citationMallipatna, A. C., Marino, M. J., & Singh, A. D. (2016) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000219 · Cited by 60
“A retinoma is a rare, benign variant of retinoblastoma also caused by mutations in the RB1 gene.(18) Studies have shown that retinoma is a precursor of retinoblastoma.”
BackgroundGenomic differences between retinoma and retinoblastoma
Sampieri, K., Mencarelli, M. A., Epistolato, M. C., Toti, P., Lazzi, S., Bruttini, M., Francesco, S. D., Longo, I., Meloni, I., Mari, F., et al. (2008) · Acta Oncologica · doi:10.1080/02841860802342382 · Cited by 60
“Our results not only confirm the importance of MDM4 gain in retinoblastoma development, but interestingly suggest that it may be involved in the early transition to retinoma (Figure 4a).”
InfluentialNational retinoblastoma strategy Canadian guidelines for care
(2009) · Canadian Journal of Ophthalmology · doi:10.3129/i09-194 · Cited by 75
Retinoblastoma Origins and Destinations
Cobrinik, D. E. (2024) · New England Journal of Medicine · doi:10.1056/nejmra1803083 · Cited by 61
Strong association between cancer and genomic instability
Streffer, C. (2009) · Radiation and Environmental Biophysics · doi:10.1007/s00411-009-0258-4 · Cited by 56
“Retinoblastoma Increased (Dimaras et al. 2008) Increased (Dimaras et al. 2008) Radiat Environ Biophys (2010) 49:125–131 127”
BackgroundInfluentialRetinoblastoma: what is new in 2007–2008
Schefler, A. C., & Abramson, D. H. (2008) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e328312975b · Cited by 55
Genetic and Epigenetic Discoveries in Human Retinoblastoma
McEvoy, J. D., & Dyer, M. A. (2015) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2015013711 · Cited by 57
MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway
Wan, W., Wan, W., Long, Y., Li, Q., Jin, X., Wan, G., Zhang, F., Lv, Y., Zheng, G., Li, Z., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109111 · Cited by 51
Cdh11 Acts as a Tumor Suppressor in a Murine Retinoblastoma Model by Facilitating Tumor Cell Death
Marchong, M. N., Yurkowski, C., Ma, C., Spencer, C., Pajovic, S., & Gallie, B. L. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000923 · Cited by 55
Self-citationWhole chromosome instability resulting from the synergistic effects of pRB and p53 inactivation
Manning, A. L., Benes, C. H., & Dyson, N. J. (2013) · Oncogene · doi:10.1038/onc.2013.201 · Cited by 54
The Motor Protein KIF14 Inhibits Tumor Growth and Cancer Metastasis in Lung Adenocarcinoma
Hung, P.-F., Hong, T.-M., Hsu, Y., Chen, H., Chang, Y., Wu, C., Chang, G., Jou, Y., Pan, S., & Yang, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061664 · Cited by 51
“showed that KIF14 is highly expressed in retinoblastoma, breast cancer, ovarian cancer, hepatocellular carcinoma, glioma and some lung tumors [28,51–55].”
BackgroundInsights from mouse models into human retinoblastoma
MacPherson, D. P. (2008) · Cell Division · doi:10.1186/1747-1028-3-9 · Cited by 51
To, K.-H., Pajovic, S., Gallie, B. L., & Thériault, B. L. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-69 · Cited by 52
“However in retinoblastoma, TP53 mutation has not been reported, and alternative modes of p53 inactivation implicating MDM2 and MDM4 have been suggested but remain to be confirmed, since the expression of MDM2 in retinoblastomas is similar to retina [7-9] and MDM4 is situated in a region of frequent genomic gain (chrom…”
BackgroundSelf-citationRecent progress in retinoblastoma: Pathogenesis, presentation, diagnosis and management
Zhou, M., Tang, J., Fan, J., Wen, X., Shen, J., Jia, R., Chai, P., & Fan, X. (2024) · Asia-Pacific Journal of Ophthalmology · doi:10.1016/j.apjo.2024.100058 · Cited by 53
Array comparative genomic hybridization in retinoma and retinoblastoma tissues
Sampieri, K., Amenduni, M., Papa, F. T., Katzaki, E., Mencarelli, M. A., Marozza, A., Epistolato, M. C., Toti, P., Lazzi, S., Bruttini, M., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2008.01070.x · Cited by 48
Jo, D. H., Kim, J. H., Cho, C. S., Cho, Y.-L., Jun, H. O., Yu, Y. S., Min, J., & Kim, J. H. (2014) · Oncotarget · doi:10.18632/oncotarget.2546 · Cited by 46
Zugbi, S., Ganiewich, D., Bhattacharyya, A., Aschero, R., Ottaviani, D., Sampor, C., Cafferata, E. G. A., Mena, M. D., Sgroi, M., Winter, U., et al. (2020) · Cancers · doi:10.3390/cancers12092714 · Cited by 45
Indovina, P., Acquaviva, A., Falco, G. D., Rizzo, V., Onnis, A., Luzzi, A., Giorgi, F. D., Hadjistilianou, T., Toti, P., Tomei, V., et al. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.22019 · Cited by 47
Next generation sequencing in sporadic retinoblastoma patients reveals somatic mosaicism
Amitrano, S., Marozza, A., Somma, S., Imperatore, V., Hadjistilianou, T., Francesco, S. D., Toti, P., Galimberti, D., Meloni, I., Cetta, F., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.6 · Cited by 44
Marshall, A. E., Roes, M. V., Passos, D. T., DeWeerd, M. C., Chaikovsky, A. C., Sage, J., Howlett, C. J., & Dick, F. A. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00105-19 · Cited by 47
“Primary RB1 / cells from a number of sources are prone to mitotic errors (16–18), and precursor lesions to retinoblastoma are characterized by aneuploidy (41), suggesting that this is an early step in this disease.”
BackgroundThe 5th Edition of the World Health Organization Classification of Tumours of the Eye and Orbit
Milman, T., Grossniklaus, H. E., Goldman‐Lévy, G., Kivelä, T., Coupland, S. E., White, V. A., Mudhar, H. S., Eberhart, C. G., Verdijk, R. M., Heegaard, S., et al. (2023) · Ocular Oncology and Pathology · doi:10.1159/000530730 · Cited by 43
Eloy, P., Dehainault, C., Sefta, M., Aerts, I., Doz, F., Cassoux, N., Rouïc, L. L.-L., Stoppa‐Lyonnet, D., Radvanyi, F., Millot, G. A., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005888 · Cited by 45
“Since it has been described that retinoma develops after homozygous loss of RB1[24], individuals with retinoma were considered to be affected.”
BackgroundRecent advances in retinoblastoma genetic research
Nichols, K. E., WALTHER, S. E., Chao, E., Shields, C. L., & Ganguly, A. A. (2009) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e32832f7f25 · Cited by 46
Kurzawa‐Akanbi, M., Tzoumas, N., Corral-Serrano, J. C., Guarascio, R., STEEL, D. H., Cheetham, M. E., Armstrong, L., & Lako, M. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101248 · Cited by 44
Xiao, W., Chen, X.-Y., & He, M.-G. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2213 · Cited by 45
Xu, X. L., Lee, T. C., Offor, N., Cheng, C., Liu, A., Fang, Y., Jhanwar, S. C., Abramson, D. H., & Cobrinik, D. E. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090512 · Cited by 42
Davies, H. R., Broad, K. D., Onadim, Z., Price, E. A., Zou, X., Sheriff, I., Karaa, E. K., Scheimberg, I. B., Reddy, M. A., Sagoo, M. S., et al. (2021) · Cancers · doi:10.3390/cancers13040754 · Cited by 39
“MDM4 encodes an E3 ubiquitin ligase that functions as a negative regulator of p53 activity and it has been postulated that the MDM4 gene on chromosome 1q32 is the potential oncogene driving the frequent gains of chromosome 1q in retinoblastoma [20,38].”
BackgroundComparative proteomic analysis of differentially expressed proteins in primary retinoblastoma tumors
Kandalam, M., Sundaram, C. S., Sharma, Y., Deepa, P. R., Khetan, V., Gopal, L., Biswas, J., Sharma, T., & Krishnakumar, S. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200900069 · Cited by 41
“Genomic instability contributes to the progression of retinoma to malignant RB [25–27].”
BackgroundSelf-citationCross-species genomic and epigenomic landscape of retinoblastoma
Benavente, C. A., McEvoy, J. D., Finkelstein, D., Wei, L., Kang, G., Wang, Y., Neale, G. A. M., Ragsdale, S. T., Valentine, V. A., Bahrami, A., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1051 · Cited by 40
“com/oncotarget murine cells and immortalized human cells, it was shown that RB1 plays an important role in maintaining genomic stability [2-4].”
BackgroundSradhanjali, S., Tripathy, D., Rath, S., Mittal, R., & Reddy, M. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177744 · Cited by 38
Expression of p14, MDM2, and MDM4 in human retinoblastoma
Guo, Y., Pajovic, S., & Gallie, B. L. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.055 · Cited by 44
Self-citationAbouzeid, H., Schorderet, D. F., Balmer, A., & Munier, F. L. (2009) · PubMed Central · Cited by 37
Genetics in ophthalmology: molecular blueprints of retinoblastoma
Marković, L., Bukovac, A., Varošanec, A. M., Šlaus, N., & Pećina‐Šlaus, N. (2023) · Human Genomics · doi:10.1186/s40246-023-00529-w · Cited by 35
“Losing both alleles of the RB1 tumor suppressor gene in such susceptible developing retinal cell initiates the benign precursor, retinoma, which usually progresses to retinoblastoma with accumulation of increasing genomic changes and uncontrolled cellular proliferation [13–15].”
BackgroundTranscriptional and Epigenetic Regulation of KIF14 Overexpression in Ovarian Cancer
Thériault, B. L., Basavarajappa, H. D., Lim, H., Pajovic, S., Gallie, B. L., & Corson, T. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091540 · Cited by 36
Self-citationKhetan, V., Sengupta, S., & Pan, U. (2016) · Indian Journal of Ophthalmology · doi:10.4103/0301-4738.190099 · Cited by 35
Self-citationRozanska, A. L., Cerna-Chavez, R., Queen, R. A., Collin, J., Zerti, D., Dorgau, B., Beh, C. S., Davey, T., Coxhead, J., Hussain, R., et al. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac008 · Cited by 37
LncRNAs and CircRNAs in cancer
Yin, X., Lin, H., Lin, L., Miao, L., He, J., & Zhuo, Z. (2022) · MedComm · doi:10.1002/mco2.141 · Cited by 40
Rojanaporn, D., Boontawon, T., Chareonsirisuthigul, T., Thanapanpanich, O., Attaseth, T., Saengwimol, D., Anurathapan, U., Sujirakul, T., Kaewkhaw, R., & Hongeng, S. (2018) · Europe PMC (PubMed Central) · Cited by 34
Collin, J., Queen, R. A., Zerti, D., STEEL, D. H., Bowen, C., Parulekar, M., & Lako, M. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.6.18 · Cited by 36
“30 Detailed assessment of scATAC-Seq data show an enrichment of in the accessibility of Cyclin B1 promoter and enhancer, as well as Ki67 enhancer in this subcluster, supporting its Rb definition.”
Therapeutic Strategies for RB1-Deficient Cancers: Intersecting Gene Regulation and Targeted Therapy
Huang, M.-F., Wang, Y., Chou, Y., & Lee, D. (2024) · Cancers · doi:10.3390/cancers16081558 · Cited by 34
“It is widely believed that further aberrations are necessary for complete malignant transformation in retinoblastoma [81,82].”
BackgroundSun, J., Xi, H., Shao, Q., & Liu, Q. (2020) · International Journal of Ophthalmology · doi:10.18240/ijo.2020.02.18 · Cited by 42
Phenotypic variability of retinocytomas: preregression and postregression growth patterns
Abouzeid, H., Balmer, A., Moulin, A., Mataftsi, A., Zografos, L., & Munier, F. L. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-300896 · Cited by 33
“15 17 18 Recent insights have shown that the type of inherited mutations underlying retinocytoma is undistinguishable from retinoblastoma related ones;(14) 15 in other words, severe truncating mutations can cause retinocytomas, which actually is in line with the most recent histogenetic studies.(8) Figure 3 Patient #3…”
BackgroundHill, J. A., Lee, S. Y., Njambi, L., Corson, T. W., & Dimaras, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129852 · Cited by 32
“Retinoblastoma is initiated by loss of function of the tumor suppressor gene RB1 [9].”
BackgroundSelf-citationDelhiwala, K., Vadakkal, I. P., Mulay, K., Khetan, V., & Wick, M. R. (2015) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2015.10.007 · Cited by 32
“inadequate for complete development of that tumor; other genetic and epigenetic events are necessary to that process.(14) There is increasing evidence for a role of oncogenes such as MDM4, KIF14, MYCN, DEK, and E2F3, and the tumor suppressor gene CDH11 in retinoblastomagenesis.”
BackgroundSelf-citationChen, M., Zhao, J., Xia, J., Liu, Z., Jiang, H., Shen, G., Li, H., Yizhou, J., & Zhang, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160873 · Cited by 32
“Retinoblastoma (RB) is the most common intra-ocular malignant tumor in infants and young children, affecting approximately 1 in 16000–18000 live births worldwide each year [1, 2].”
BackgroundHeterogeneity in retinoblastoma: a tale of molecules and models
Stenfelt, S., Blixt, M. K. E., All‐Ericsson, C., Hallböök, F., & Boije, H. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0173-2 · Cited by 34
“Studies have shown that retinoma is a precursor of retinoblastoma that may undergo malignant transformation [24, 76].”
BackgroundResultVariability in retinoblastoma genome stability is driven by age and not heritability
Polski, A., Xu, L., Prabakar, R. K., Gai, X., Kim, J. W., Shah, R., Jubran, R. F., Kühn, P., Cobrinik, D. E., Hicks, J. B., et al. (2020) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22859 · Cited by 32
“Although the transition from retinoma to active RB is generally attributed to the accumulation of SCNAs—which are believed to drive RB growth and progression(3,7)—previous studies have also demonstrated that SCNAs are present (although typically fewer in number) in the retinoma stage before RB formation.(3,7) It is po…”
BackgroundShields, C. L., Baş, Z., Laiton, A., Silva, A. M. V., Sheikh, A., Lally, S. E., & Shields, J. A. (2022) · Eye · doi:10.1038/s41433-022-01980-0 · Cited by 37
Khan, M., Walters, L. L., Li, Q., Thomas, D. G., Miller, J. M. L., Zhang, Q., Sciallis, A. P., Liu, Y., Dlouhy, B. J., Fort, P. E., et al. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.104 · Cited by 32
Metadata
- Authors
- Dimaras, H., Khetan, V., Halliday, W., Orlic, M., Prigoda, N. L., Piovesan, B., Marrano, P., Corson, T. W., Eagle, R. C., Squire, J. A., & Gallie, B. L.
- Affiliations
- University of Toronto (CA)
- Hospital for Sick Children (CA)
- University Health Network (CA)
- Princess Margaret Cancer Centre (CA)
- Wills Eye Hospital (US)
- Corresponding author
- Gallie, Brenda L.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-01-22
- Volume
- 17
- Issue
- 10
- Pages
- 1363-1372
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2122129374
- Cited by
- 351
- References
- 48
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 20 · 2023: 15 · 2022: 24 · 2021: 36 · 2020: 19 · 2019: 19 · 2018: 16 · 2017: 14 · 2016: 12 · 2015: 23 · 2014: 14 · 2013: 20 · 2012: 19
- FWCI
- 24.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- retinoblastoma, retinoma, genomic instability, cellular senescence, p16INK4a, p130, two-hit model, tumor suppressor, oncogene expression, aneuploidy, MYCN, E2F3, DEK, KIF14, MDM4, cadherin-11, p75 neurotrophin receptor, retinal development, tumor progression
- MeSH terms
- Adult, Gene Amplification, Homozygote, Humans, Infant, Male, Retinoblastoma, Oncogene Proteins, Tumor Suppressor Protein p53, Retinoblastoma Protein, Disease Progression, Gene Dosage, Proliferating Cell Nuclear Antigen, Ki-67 Antigen, Cyclin-Dependent Kinase Inhibitor p16, Gene Silencing, Tumor Suppressor Proteins, Genomic Instability, Cell Proliferation, Retinoblastoma-Like Protein p130
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.